Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics.

Ildiko Lingvay,Kirstine Brown-Frandsen,Helen M Colhoun,John Deanfield,Scott S Emerson,Sille Esbjerg, Søren Hardt-Lindberg,G Kees Hovingh,Steven E Kahn,Robert F Kushner,A Michael Lincoff,Steven P Marso,Tea Monk Fries,Jorge Plutzky,Donna H Ryan

Obesity (Silver Spring, Md.)（2023）

Cited 17|Views38
No score
Abstract
The enrolled population in SELECT includes participants across a broad range of relevant risk categories. This will allow the study to garner information about the CV benefits of semaglutide across these relevant clinical subgroups.
More
Translated text
Key words
semaglutide,cardiovascular event reduction,obesity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined